Literature DB >> 1919645

Malignant properties of P635 glioma are independent of glial fibrillary acidic protein expression.

A F Chambers1, G H Denhardt, S M Wilson, J G Cairncross.   

Abstract

To examine the relationship between the malignant behavior of rat glioma cells and expression of the differentiation antigen glial fibrillary acidic protein (GF), we assayed the tumorigenicity and metastatic ability of P635 and its GF+ or GF- clones. We injected P635 (GF+) and clone 45 (GF-) cells intramuscularly in nude mice. Both lines formed local tumors which metastasized to lungs with equal efficiency. We then injected these lines intravenously in nude mice. Both produced experimental metastases in lungs and other organs with equal efficiency. Finally we injected P635 and several GF+ and GF- clones into the chorioallantoic membrane veins of naturally immune-deficient chick embryos and measured cell growth in embryonic liver. We again found that all clones survived and grew equally well. P635 cells are capable of extracranial growth and metastasis, two important features of the malignant phenotype. We conclude that GF in P635 is a neutral marker with respect to tumorigenicity and metastatic ability.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1919645     DOI: 10.1007/bf00166996

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  23 in total

1.  ras-transformed NIH 3T3 cell lines, selected for metastatic ability in chick embryos, have increased proportions of p21-expressing cells and are metastatic in nude mice.

Authors:  A F Chambers; G H Denhardt; S M Wilson
Journal:  Invasion Metastasis       Date:  1990

2.  Tumor heterogeneity: biological implications and therapeutic consequences.

Authors:  G H Heppner; B E Miller
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

3.  A glial fibrillary acidic protein-expressing and tumorigenic cell line derived from an avian sarcoma virus-induced rat astrocytoma.

Authors:  Y S Lee; S H Bigner; L F Eng; P Molnar; A Kuruvilla; D R Groothuis; D D Bigner
Journal:  J Neuropathol Exp Neurol       Date:  1986-11       Impact factor: 3.685

4.  Co-expression of glial fibrillary acidic protein- and vimentin-type intermediate filaments in human astrocytomas.

Authors:  M J Herpers; F C Ramaekers; J Aldeweireldt; O Moesker; J Slooff
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

Review 5.  Oncogene transformation and the metastatic phenotype.

Authors:  A F Chambers; A B Tuck
Journal:  Anticancer Res       Date:  1988 Sep-Oct       Impact factor: 2.480

6.  Transplantability and metastatic potential of chemically induced rat brain tumours.

Authors:  B Maat; M J van Zwieten; D W van Bekkum; C Vecht
Journal:  Biomedicine       Date:  1979-12

7.  Products of cells cultured from gliomas. VI. Immunofluorescent, morphometric, and ultrastructural characterization of two different cell types growing from explants of human gliomas.

Authors:  P E McKeever; B H Smith; J A Taren; R L Wahl; P L Kornblith; B M Chronwall
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

8.  Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells.

Authors:  R P Hill; A F Chambers; V Ling; J F Harris
Journal:  Science       Date:  1984-06-01       Impact factor: 47.728

9.  Astrocyte cell lineage. I. Astrocyte progenitor cells in mouse neopallium.

Authors:  B H Juurlink; S Fedoroff; C Hall; E J Nathaniel
Journal:  J Comp Neurol       Date:  1981-08-10       Impact factor: 3.215

Review 10.  Metastatic anaplastic oligodendroglioma.

Authors:  D R Macdonald; R A O'Brien; J J Gilbert; J G Cairncross
Journal:  Neurology       Date:  1989-12       Impact factor: 9.910

View more
  1 in total

1.  Human and rat glioma growth, invasion, and vascularization in a novel chick embryo brain tumor model.

Authors:  Alexandra Cretu; Joseph S Fotos; Brian W Little; Deni S Galileo
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.